转录因子ATMIN在鼻癌中促进化学抵抗
Xue-Liang Fang1, Qing-Jie Li1, Jia-Yi Lin1
1Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Center for Precision Medicine of Sun Yat-sen University, Guangzhou, 510060, PR China.
Cell death & disease
|February 6, 2024
概括
研究人员确定ATMIN是鼻癌 (NPC) 化学抵抗TPF治疗的关键因素. 针对USP10-ATMIN-LCK通路可能会改善NPC患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 先进的鼻癌 (NPC) 治疗依赖于多塞塔克塞尔-西斯普拉丁-5-甲 (TPF) 化疗,但化学抵抗限制了疗效.
- 在NPC中驱动TPF化学抵抗的分子机制尚未完全理解.
研究的目的:
- 为了确定参与NPC中TPF化学抵抗的新基因和途径.
- 阐明ATMIN在NPC化学抵抗中的功能作用及其调节机制.
主要方法:
- 对基因表达微阵列数据和患者存活率的分析.
- 质谱和共免疫沉 (Co-IP) 测试.
- 在体外和体外的淘汰/过度表达研究.
- 染色体免疫沉降测序 (ChIP-seq) 和RNA测序 (RNA-seq).
主要成果:
- 转录因子ATMIN被确定为NPC中的化学抵抗基因.
- USP10使ATMIN脱和稳定,从而导致其高表达.
- ATMIN knockdown 增加了多塞塔克塞尔的敏感性,而过度表达则降低了它.
- ATMIN通过转录激活和稳定LCK,促进增殖和化学抵抗.
结论:
- USP10-ATMIN-LCK轴是NPC中TPF化学抵抗的一个关键机制.
- 针对这个轴,为管理NPC提供了潜在的治疗策略.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Co-activators and Co-repressors
7.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.4K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
RNA Polymerase II Accessory Proteins
9.2K
Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
9.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


